Cyclosporine A (CsA) 2-h concentrations vary between patients without correlation to graft-versus-host disease after allogeneic haematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Cyclosporine A (CsA) 2-h concentrations vary between patients without correlation to graft-versus-host disease after allogeneic haematopoietic stem cell transplantation

Published:2007-07-30 Issue:7 Volume:40 Page:683-689
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Barkholt L,Remberger M,Bodegård H,Ringdén O,Böttiger Y

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1705788.pdf

Reference29 articles.

1. Cantarovich M, Fitchett D, Latter DA . Cyclosporine trough levels, acute rejection, and renal dysfunction after heart transplantation. Transplantation 1995; 59: 444–447.

2. Cole E, Keown P, Landsberg D, Halloran P, Shoker A, Rush D et al. Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow-up in stable renal transplant recipients: a report of the Canadian Neoral Renal Study Group. Transplantation 1998; 65: 505–510.

3. Halloran PF, Helms LM, Kung L, Noujaim J . The temporal profile of calcineurin inhibition by cyclosporine in vivo. Transplantation 1999; 68: 1356–1361.

4. Cantarovich M, Elstein E, de Varennes B, Barkun JS . Clinical benefit of neoral dose monitoring with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients. Transplantation 1999; 68: 1839–1842.

5. Morris RG, Russ GR, Cervelli MJ, Juneja R, McDonald SP, Mathew TH . Comparison of trough, 2-hour, and limited AUC blood sampling for monitoring cyclosporin (Neoral) at day 7 post-renal transplantation and incidence of rejection in the first month. Ther Drug Monit 2002; 24: 479–486.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population pharmacokinetics of cyclosporine A in hematopoietic stem cell transplant recipients: A systematic review;European Journal of Pharmaceutical Sciences;2024-08

2. Comparison of mycophenolate mofetil and calcineurin inhibitor versus calcineurin inhibitor-based graft-versus-host-disease prophylaxis for matched unrelated donor transplant in acute myeloid leukemia. A study from the ALWP of the EBMT;Bone Marrow Transplantation;2020-11-28

3. Evaluation of Cyclosporine Pharmacokinetic, Monitoring, and Dosing Parameters for GVHD Prophylaxis in Hematopoietic Stem Cell Transplant (HSCT) Recipients;IRAN J PHARM RES;2019

4. Pharmacokinetics, Pharmacodynamics and Pharmacogenomics of Immunosuppressants in Allogeneic Haematopoietic Cell Transplantation: Part I;Clinical Pharmacokinetics;2015-11-13

5. Cyclosporine use in hematopoietic stem cell transplantation: pharmacokinetic approach;Immunotherapy;2015-07